Position in CAI
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$1,120,646
+$343,153 QoQ
Shares Held
62,887
+44.6% QoQ
Ownership
0.022%
of shares outstanding
% of Portfolio
0.62%
of 13F equity value
Holder Rank
#87
of 246 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CAI Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Renaissance Capital LLC holds $4,099,107 across 2 Biotechnology names. CAI ranks #2 (27.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | APGE |
Apogee Therapeutics, Inc.
|
22,440 | $2,978,461 | |
| 2 | CAI |
Caris Life Sciences, Inc.
This page
|
62,887 | $1,120,646 |
All Filings in CAI
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,120,646 | 62,887 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $777,493 | 43,484 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $389,294 | 14,429 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $860,915 | 28,460 | Shares | Sole | 2025-10-20 | |
| No filing history on record for this holder in this stock. | ||||||